TCL Archive NCI plans to cut staff access to The Cancer Letter; insiders allege attempt at “thought control.” November 18, 2005
TCL Archive FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer April 29, 1988